Sensus Healthcare (SRTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sensus Healthcare, Inc. (SRTS) closed at $5.99 in the latest trading session, marking a -0.66% move from the prior day.
Sensus Healthcare (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.
Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.
Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $5.48, signifying a -0.54% move from its prior day's close.
Sensus Healthcare, Inc. (SRTS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SRTS crossed above the 20-day moving average, suggesting a short-term bullish trend.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare (SRTS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here is how Sensus Healthcare, Inc. (SRTS) and Aileron Therapeutics, Inc. (ALRN) have performed compared to their sector so far this year.